Last reviewed · How we verify
NCT04931316: Dalk
Incidence and Management of Ocular Hypertension Following Deep Anterior Lamellar Keratoplasty
trial testing antiglaucoma in Unrecognized Condition in 10 participants. Status unknown.
20 September 2021
Quick facts
| Lead sponsor | Mansoura University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 15 March 2021 |
| Primary completion | 20 September 2021 |
| Estimated completion | 20 October 2021 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- antiglaucoma
Conditions studied
- Unrecognized Condition — all drugs for Unrecognized Condition →
Sponsor
Mansoura University
Who can join
Adults 18 to 60, any sex, with Unrecognized Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a retrospective case series study that included patients who performed deep anterior lamellar keratoplasty and presented with elevated intraocular pressure during follow up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04931316
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Unrecognized Condition
Currently open trials in the same condition.
- NCT06803199 — Effects of LH and FSH on Metabolic Regulation in Cumulus Cells · NA · recruiting
- NCT06661967 — Topical Oral Anesthesia Adjuncts in Conventional Intubation on First-Pass Success Rate · NA · recruiting
- NCT06243146 — Titration of Inspired Oxygen to Decrease the Incidence of Postoperative Pulmonary Complications · NA · recruiting
- NCT06339996 — Male Supplements for Sperm Quality and Aging · NA · recruiting
- NCT05873075 — Intravascular Laser Irradiation of Blood Use in Poor Ovarian Responders · NA · active not recruiting
Other Mansoura University trials
Trials by the same sponsor.
- NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
- NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
- NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
- NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04931316 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University
- Last refreshed: 23 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04931316.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing